FIELD: medicine. SUBSTANCE: this composition includes metrodidazole, solvent and buffer system having pH value of 3 to 4.25. Proposed method prescribes treating vagina affected by infection with metronidazole 1 to 3 times a day during 3 to 10 days. EFFECT: no side effects. 2 dwg, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
VAGINAL GEL | 2021 |
|
RU2834988C1 |
COMPOSITION AND METHOD TO CONTROL AND MAINTAIN BACTERIAL MICROFLORA AND ACIDITY OF VAGINA | 2006 |
|
RU2409368C2 |
TOPICAL DERMAL COMPOSITION CONTAINING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS, AND USING IT | 2010 |
|
RU2536264C2 |
DRUG DELIVERY POLYMER WITH CLINDAMYCIN HYDROCHLORIDE | 2007 |
|
RU2444364C2 |
USE OF TOTAROL AND PHARMACEUTICAL COMPOSITION CONTAINING TOTAROL | 2018 |
|
RU2812223C2 |
LYOPHILIZED PHARMACEUTICAL COMPOSITIONS FOR VAGINAL DELIVERY | 2017 |
|
RU2753864C2 |
LOW-CONCENTRATED PEROXIDE FOR TREATMENT OR PREVENTION OF VAGINAL INFECTIONS | 2002 |
|
RU2329829C2 |
PHARMACEUTICAL COMPOSITION FOR TOPICAL TREATMENT OF INFLAMMATION AND METHOD FOR ITS PREPARING | 2001 |
|
RU2272636C2 |
USING LACTIC ACID OLIGOMERS IN TREATING GYNAECOLOGICAL DISORDERS | 2008 |
|
RU2459620C2 |
COMPOSITION SHOWING ANALGETIC OR ANTIINFLAMMATORY ACTIVITY, A METHOD OF ANALGIA OR TREATMENT OF ALLERGIC DISEASES | 1990 |
|
RU2095060C1 |
Authors
Dates
1995-04-10—Published
1991-02-05—Filed